Sponsor Pipeline

Charm Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
2
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-08-07 NCT07751991 A Study of CHM-029 in Participants With NPM1 Mutated, KMT2A or NUP98 Rearranged AML Phase 1 Recruiting
Active Trials by Phase
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07751991 A Study of CHM-029 in Participants With NPM1 Mutated, KMT2A or NUP98 Rearranged AML AML (Acute Myeloid Leukemia) Recruiting
Disease Areas
Leukemia (1) Acute Myeloid Leukemia (AML) (1)
Get alerts when Charm Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free